Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal-spraying LiveSpo X-secret for STIs in Vietnamese Women
NCT05783856Completed
- Sponsor
- AnaBio Technologies
- Start
- May 2020
- Primary completion
- Mar 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of LiveSpo X-secret in sexually transmitted infections (STI) (2 arms), sponsored by AnaBio Technologies. Primary endpoint: Percentage of patients with free and/or reduced gynecological infection symptoms. Started May 2020; status: completed.
02
Drugs
LiveSpo X-secret
03
Conditions
sexually transmitted infections (STI)
Beyond the preview
Go deeper on NCT05783856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05783856.